The therapy is approved by the U.S. Food and Drug Administration for relapsed or treatment - resistant Hodgkin lymphoma, and it is commonly prescribed to patients whose disease has progressed
after autologous stem cell transplant, a procedure that replenishes the bone marrow with the patient's own healthy stem cells after therapy.
Not exact matches
While some previous studies found that maintenance lenalidomide
after autologous hematopoietic
stem cell transplant improved overall survival for newly diagnosed multiple myeloma patients, others showed no benefit to this approach.
The study, «Lenalidomide (LEN) maintenance (MNTC)
after high - dose melphalan and
autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta - analysis (MA) of overall survival (OS),» is ASCO 2016 abstract no. 8001 and will be discussed during the Hematologic Malignancies — Plasma Cell Dyscrasia oral abstract session Friday, Jun
cell transplant (ASCT) in multiple myeloma (MM): A meta - analysis (MA) of overall survival (OS),» is ASCO 2016 abstract no. 8001 and will be discussed during the Hematologic Malignancies — Plasma
Cell Dyscrasia oral abstract session Friday, Jun
Cell Dyscrasia oral abstract session Friday, June 3.
Results from a clinical trial investigating a new T
cell receptor (TCR) therapy that uses a person's own immune system to recognize and destroy cancer
cells demonstrated a clinical response in 80 percent of multiple myeloma patients with advanced disease
after undergoing
autologous stem cell transplants (ASCT).
Pattern of employment and associated factors in long - term lymphoma survivors 10 years
after high - dose chemotherapy with
autologous stem cell transplantation.
A national study on conditional survival, excess mortality and second cancer
after high dose therapy with
autologous stem cell transplantation for non-Hodgkin lymphoma.
Conditional survival and excess mortality
after high - dose therapy with
autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway.
Vision Loss
after Intravitreal Injection of
Autologous «
Stem Cells» for AMD.
In a previous study by the same group 78,
autologous culture - expanded MSC were infused to breast cancer patients to investigate whether MSC would enhance the engraftment of peripheral blood
stem cells after myeloablative therapy.
Hematopoietic
stem cells express the markers CD34 and CD133 and can repopulate a myeloablated recipient
after allogeneic or
autologous transplantation.
The US Food and Drug Administration (FDA) has granted Priority Review designation for tisagenlecleucel (Kymriah), formerly known as CTL019, for treatment of adult patients with relapsed or refractory diffuse large B -
cell lymphoma (DLBCL) who are ineligible for, or have relapsed
after,
autologous stem cell transplant.
That happened right before my
autologous stem cell transplant,
after I'd done one more round of chemotherapy before my
stem cells were harvested.
After learning about
autologous stem cell therapy and how it could help her, we raised money to help the rescue pay for her treatment.
After experiencing how
autologous adult
stem cell therapy helped a loved one struggling with Multiple Sclerosis regain their life quality, Stemedix was founded with the determination to help offer this alternative therapy to others around the world suffering from debilitating diseases.